Unknown

Dataset Information

0

Early Postnatal Treatment with Valproate Induces Gad1 Promoter Remodeling in the Brain and Reduces Apnea Episodes in Mecp2-Null Mice.


ABSTRACT: The deletion of Mecp2, the gene encoding methyl-CpG-binding protein 2, causes severe breathing defects and developmental anomalies in mammals. In Mecp2-null mice, impaired GABAergic neurotransmission is demonstrated at the early stage of life. GABAergic dysfunction in neurons in the rostral ventrolateral medulla (RVLM) is considered as a primary cause of breathing abnormality in Mecp2-null mice, but its molecular mechanism is unclear. Here, we report that mRNA expression levels of Gad1, which encodes glutamate decarboxylase 67 (GAD67), in the RVLM of Mecp2-null (Mecp2-/y, B6.129P2(C)-Mecp2tm1.1Bird/J) mice is closely related to the methylation status of its promoter, and valproate (VPA) can upregulate transcription from Gad1 through epigenetic mechanisms. The administration of VPA (300 mg/kg/day) together with L-carnitine (30 mg/kg/day) from day 8 to day 14 after birth increased Gad1 mRNA expression in the RVLM and reduced apnea counts in Mecp2-/y mice on postnatal day 15. Cytosine methylation levels in the Gad1 promoter were higher in the RVLM of Mecp2-/y mice compared to wild-type mice born to C57BL/6J females, while VPA treatment decreased the methylation levels in Mecp2-/y mice. Chromatin immunoprecipitation assay revealed that the VPA treatment reduced the binding of methyl-CpG binding domain protein 1 (MBD1) to the Gad1 promoter in Mecp2-/y mice. These results suggest that VPA improves breathing of Mecp2-/y mice by reducing the Gad1 promoter methylation, which potentially leads to the enhancement of GABAergic neurotransmission in the RVLM.

SUBMITTER: Ishiyama M 

PROVIDER: S-EPMC6834123 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Early Postnatal Treatment with Valproate Induces <i>Gad1</i> Promoter Remodeling in the Brain and Reduces Apnea Episodes in <i>Mecp2</i>-Null Mice.

Ishiyama Misa M   Tamura Satoko S   Ito Hisanori H   Takei Hiroki H   Hoshi Manami M   Asano Masatake M   Itoh Masayuki M   Shirakawa Tetsuo T  

International journal of molecular sciences 20191018 20


The deletion of <i>Mecp2</i>, the gene encoding methyl-CpG-binding protein 2, causes severe breathing defects and developmental anomalies in mammals. In <i>Mecp2</i>-null mice, impaired GABAergic neurotransmission is demonstrated at the early stage of life. GABAergic dysfunction in neurons in the rostral ventrolateral medulla (RVLM) is considered as a primary cause of breathing abnormality in <i>Mecp2</i>-null mice, but its molecular mechanism is unclear. Here, we report that mRNA expression lev  ...[more]

Similar Datasets

| S-EPMC4844233 | biostudies-literature
| S-EPMC1794312 | biostudies-literature
| S-EPMC3234513 | biostudies-literature
| S-EPMC2576441 | biostudies-literature
| S-EPMC8474908 | biostudies-literature
| S-EPMC2838567 | biostudies-literature
| S-SCDT-EMM-2020-12433 | biostudies-other
| S-EPMC5424572 | biostudies-literature
| S-EPMC8033520 | biostudies-literature
| S-EPMC3412380 | biostudies-literature